Armstrong Coal Company, Inc. v. Nathan Attebury

CourtKentucky Supreme Court
DecidedApril 25, 2017
Docket2016 SC 000368
StatusUnknown

This text of Armstrong Coal Company, Inc. v. Nathan Attebury (Armstrong Coal Company, Inc. v. Nathan Attebury) is published on Counsel Stack Legal Research, covering Kentucky Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Armstrong Coal Company, Inc. v. Nathan Attebury, (Ky. 2017).

Opinion

lMPORTANT NOT|CE NOT TO BE PUBL|SHED OP|N|ON

TH|S OP|N|ON lS DES|GNATED ”NOT TO BE PUBL|SHED." PURSUANT TO THE RULES OF ClVlL PROCEDURE PROMULGATED BY THE SUPREME COURT, CR 76.28(4)(€), THlS OP|N|ON lS NOT TO BE PUBL|SHED AND SHALL NOT BE ClTED OR USED AS BlND|NG PRECEDENT lN ANY OTHER CASE lN ANY COURT OF TH|S STATE; HOWEVER, UNPUBL|SHED KENTUCKY APPELLATE DEC|S|ONS, RENDERED AFTER JANUARY 1, 2003, MAY BE ClTED FOR CONS|DERAT|ON BY THE COURT lF THERE lS NO PUBL|SHED OP|N|ON THAT WOULD ADEQUATELY ADDRESS THE lSSUE BEFORE THE COURT. OP|N|ONS ClTED FOR CONS|DERAT|ON BY THE COURT SHALL BE SET OUT AS AN UNPUBL|SHED DEC|S|ON lN THE FlLED DOCUMENT AND A COPY OF THE ENT|RE DEC|S|ON SHALL BE TENDERED ALONG WlTH THE DOCUMENT TO THE COURT AND ALL PARTIES TO THE ACT|ON.

RENDERED: APRIL 27, 2017 NOT TO BE PUBLISHED

§upreme Court of Beniuckg

2016-SC-000368-WC ARMSTRONG COAL COMPANY, INC. APPELLANT

ON APPEAL FROM COURT OF APPEALS CASE NO. 2015-CA-001545-WC V. WORKERS’ COMPENSATION BOARD NO. 14-WC-90179

NATHAN ATTEBURY; APPELLEES HON. CHRIS DAVIS, ADMINISTRATIVE LAW JUDGE; AND 'WORKERS’ COMPENSATION BOARD MEMORANDUM OPINION OF THE COURT AFFIR.MING

An Adrninistrative Law Judge (ALJ) found that Nathan Attebury developed toxic encephalopathy and is permanently totally disabled as a result of exposure to toluene, a chemical in Krylon paint, while working for Armstrong Coal Company, Inc. The Workers’ Compensation Board (the Board) aftirmed, as did a divided panel of the Court of Appeals. On appeal to this Court, Armstrong argues, as it did below, that the ALJ’s findings were not supported by evidence of Substance. For the following reasons, we disagree and affirm.

I. BACKGROUND. Attebury was born on June 8, 1981. He has a high school education and

his mine-foreman certification, and he has worked as a construction laborer, in

a clothing factory, and as an underground coalrniner. Approxirnately six

months after he started working for Armstrong, Attebury began to experience headaches, dizziness, short-term memory loss, and confusion. His symptoms progressiver worsened, and he stopped working in January 2014.

Attebury testified that he had previously suffered from seasonal affective disorder, for which he took an anti-depressant, and from panic attacks, anxiety, and headaches. Attebury also testified that he had been prescribed Suboxone in order to wean himself from Lortab that he took following a neck injury.

Attebury first sought treatment for his symptoms with Dr. Jayna Jones in January 2014. Dr. Jones noted that Attebury complained of dizziness, headaches, memory loss, social anxiety, occasional “blackout spells,” and confusion. Attebury attributed his symptoms to the paint he was using at work and stated that his symptoms improved when he was off work for any length of time. Dr. Jones referred Attebury to Dr. Michael Mayron, a ` neurologist.

Dr. Mayron, who first treated Attebury on February 17, 2014, noted that Attebury had neuropathy in his left arm and leg, tremors in both hands, and severe memory impairment Following his examination and a review of medical literature, Dr. Mayron made a diagnosis of toxic encephalopathy, which he attributed to Attebury’s exposure to the chemical toluene, a component of the Krylon spray paint Attebury used at work. Based on Attebury’s memory loss and inability to perform multi-step tasks, Dr. Mayron assigned him a 49%

impairment rating. In his report and during his deposition, Dr. Mayron

referred to an article from the Annals of Neurology from June 1988 to support his conclusions that Attebury’s condition was related to exposure to toluene. During his deposition, Dr. Mayron stated that he had reviewed other articles, which he did not have readily available. However, he supplied copies of those articles to the court reporter after his deposition, We discuss the articles Dr. Mayron relied on in more detail below.

Armstrong filed the report of Dr. Dennis O’Keefe, a neurologist who performed an independent medical evaluation of Attebury at Armstrong’s request. In his report, Dr. O’Keefe stated that Attebury complained of depression, anxiety, headaches, and memory loss that became severe in December 2013. Dr. O’Keefe’s examination revealed deficits in immediate recall, attention, and calculation; an “essentially normal” ability to speak and answer questions; and lightheadedness after two minutes of hyperventilation. Dr. O’Keefe stated that two chemicals in Krylon paint could cause neurological problems: xylene, which causes dizziness, lightheadedness, and other symptoms; and N-hexane, which causes neuropathy in the extremities. He noted that Attebury had no symptoms of extremity neuropathy and that symptoms associated with xylene exposure generally resolve once exposure to the chemical stops. Based on the preceding, Dr. O’Keefe concluded that Attebury’s symptoms were not related to exposure to chemicals in Krylon but to Attebury’s depression, which Dr. O’Keefe attributed to “claustrophobia

associated with” working in an underground coalmine.

Before the ALJ, Armstrong argued that Dr. Mayron’s opinion regarding causation was not probative because he: had no history of Attebury’s prior complaints of headaches; relied on literature that pertained “to a different type of toluene exposure testing in a different type of injury;” and did not know how much Krylon Attebury used, how he used it, how often he used it, or whether Attebury had any other exposure to toluene. Armstrong also argued that the amount of toluene Attebury was exposed to was below OSHA’s permissible limits.

The ALJ disagreed with Armstrong and found as follows:

On the issue of causation both Dr. Mayron and Dr. O’Keefe have provided an opinion. Both have independently researched the effects of the Krylon paint used by the Plaintiff. Both have concluded that the paint can cause neurological effects. From that point their opinions diverge.

Dr. O’Keefe believes the paint can cause two different types of neurological condition[s]. The first, primarily effecting the limbs, the Plaintiff does not have. The second, according to Dr. O’Keefe, is not permanent and its effects should resolve entirely when exposure to the paint stops. Dr. O’Keefe affirmatively states the Plaintiff does not have toxic encephalopathy, regardless of causation. Dr. O’Keefe affirmatively states the Plaintiff has no work-related condition.

Dr. Mayron states that one of the potential side effects of the Krylon paint is toxic encephalopathy. This is the diagnosis he makes for the Plaintiff. He states the toxic encephalopathy is work-related. Dr. Mayron testified in his deposition that he extensively reviewed the Krylon paint, particularly the toluene. It can cause the toxic encephalopathy and it can cause all of the Plaintiff"s neurologic symptoms. The damage is permanent. In short, while I respect both physicians who provided an opinion regarding causation I am more inclined to find the opinion of Dr. Mayron persuasive. He is a treating physician with no known or demonstrated bias. His is a very specific field and area of expertise to which he devotes his practice, i.e. neurological conditions. He has demonstrated the scholarly texts he relies upon. There is no

other known source of causation for the Plaintiff’s symptoms, as I agree that the ADHD, anxiety or depression is not causing.them.

I am not persuaded by the Defendant’s argument that Dr. Mayron

had insufficient knowledge regarding the amount of toluene

exposure. The Plaintiff testified to me and related to Dr. Mayron

his exposure levels. That it was not measured in parts per milliliter

or some other scientifically exact amount is not decisive.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Ira A. Watson Department Store v. Hamilton
34 S.W.3d 48 (Kentucky Supreme Court, 2000)
Whittaker v. Rowland
998 S.W.2d 479 (Kentucky Supreme Court, 1999)
Johnson v. Commonwealth
12 S.W.3d 258 (Kentucky Supreme Court, 1999)
City of Owensboro v. Adams
136 S.W.3d 446 (Kentucky Supreme Court, 2004)
Toyota Motor Corp. v. Gregory
136 S.W.3d 35 (Kentucky Supreme Court, 2004)
Western Baptist Hospital v. Kelly
827 S.W.2d 685 (Kentucky Supreme Court, 1992)
Wolf Creek Collieries v. Crum
673 S.W.2d 735 (Court of Appeals of Kentucky, 1984)
Shalaby v. Bernzomatic
281 F.R.D. 565 (S.D. California, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Armstrong Coal Company, Inc. v. Nathan Attebury, Counsel Stack Legal Research, https://law.counselstack.com/opinion/armstrong-coal-company-inc-v-nathan-attebury-ky-2017.